Header Logo

Connection

GARY J WHITMAN to Germ-Line Mutation

Back to Details
This is a "connection" page, showing publications GARY J WHITMAN has written about Germ-Line Mutation.
GARY J WHITMAN
Connection Strength
0.064
Germ-Line Mutation
  1. Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA Mutation. Clin Cancer Res. 2022 09 01; 28(17):3669-3676.
    View in: PubMed
    Score: 0.035
  2. Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant. J Clin Oncol. 2020 02 10; 38(5):388-394.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.